Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Steve Yemm as Chief Commercial Officer (CCO), the latest in a series of senior-level hires as the Company rapidly expands.
read more
Tuesday, January 17, 2023
Catalent, Inc. announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America.
read more
Tuesday, January 17, 2023
Be The Match BioTherapies® announced it is offering CIBMTR® (Center for International Blood and Marrow Transplant Research) Clinical Research Organization Services (CRO Services), which allows sponsors to significantly reduce the time required to ...
read more
Tuesday, January 17, 2023
THREAD announced a five-year collaboration with, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (...
read more
Tuesday, January 17, 2023
Lonza announced two new collaborations with McSAF and Cristal Therapeutics to expand its bioconjugates offering.
read more
Tuesday, January 17, 2023
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation ...
read more
Tuesday, January 17, 2023
TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient ...
read more
Wednesday, January 18, 2023
Charles River Laboratories International, Inc and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization...
read more
Thursday, January 19, 2023
Cryoport, Inc. announced a new strategic partnership with Syneos Health® that will support the global advancement of cell and gene therapies, providing a fully integrated biopharmaceutical and supply chain solution.
read more
Thursday, January 19, 2023
Cambrex has completed its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Thursday, January 19, 2023
Eurofins Scientific has announced the acquisition of assets to establish a fully-equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad.
read more
Almac Pharma Services has announced the appointment of two new Vice Presidents. Both will serve on the Almac Pharma Services’ Executive Leadership Team, reporting directly to John McQuaid, President & Managing Director of Almac Pharma Services.
read more
Tuesday, January 24, 2023
AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), announced a new commercial manufacturing project at its Seattle protein biologics manufacturing site.
read more
Tuesday, January 24, 2023
Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company announced the expansion of its analytical laboratory and services. The new laboratory is located in the same office park as Experic’s ...
read more
Tuesday, January 24, 2023
Elligo Health Research® has introduced DataAI Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, DataAI Connect creates efficiencies across the clinical study ...
read more